Visit GobyMeds.com to learn more, schedule your consultation, and access personalized care
If you want help identifying which medication might fit your needs, you can check your eligibility here
Reasonable Consumer Standard
The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
Authored by: Sergey Terushkin, MD, FACS, FASMBS, DABOM, DABS-FPMBS Key Takeaways When you start a powerful metabolic medication like Mounjaro (Tirzepatide) or Zepbound , you expect certain changes